TMO - Thermo Fisher Scientific - Stock & Dividends

Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US8835561023

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts. Web URL: https://www.thermofisher.com

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for TMO - Thermo Fisher Scientific  - Stock & Dividends

TMO Stock Overview

Market Cap in USD 236,933m
Sector Healthcare
Industry Diagnostics & Research
GiC SubIndustry Life Sciences Tools & Services
TER 0.00%
IPO / Inception 1978-01-13

TMO Stock Ratings

Growth 5y 69.6
Fundamental 47.0
Dividend 13.3
Rel. Performance vs Sector -0.33
Analysts 4.21/5
Fair Price Momentum 614.69 USD
Fair Price DCF 520.04 USD

TMO Dividends

Dividend Yield 12m 0.25%
Yield on Cost 5y 0.53%
Dividends CAGR 5y 13.00%
Payout Consistency 36.2%

TMO Growth Ratios

Growth 12m 20.39%
Growth Correlation 12m 84%
Growth Correlation 3m 64%
CAGR 5y 15.90%
CAGR/Mean DD 5y 1.38
Sharpe Ratio 12m 0.73
Alpha vs SP500 12m -6.82
Beta vs SP500 5y weekly 0.74
ValueRay RSI 26.40
Volatility GJR Garch 1y 19.66%
Price / SMA 50 -1.71%
Price / SMA 200 4.35%
Current Volume 871.5k
Average Volume 20d 1219.5k

External Links for TMO Stock

News
Wall Street JournalBenzingaYahoo Finance
Tweets
XStocktwits
Fund Manager Positions
DataromaStockcircle
What is the price of TMO stocks?
As of October 05, 2024, the stock is trading at USD 598.61 with a total of 871,514 shares traded.
Over the past week, the price has changed by -2.57%, over one month by -2.11%, over three months by +10.90% and over the past year by +20.98%.
What are the forecast for TMO stock price target?
According to ValueRays Forecast Model, TMO Thermo Fisher Scientific will be worth about 672.2 in October 2025. The stock is currently trading at 598.61. This means that the stock has a potential upside of +12.29%.
Issuer Forecast Upside
Wallstreet Target Price 643.9 7.57
Analysts Target Price 601.9 0.55
ValueRay Target Price 672.2 12.3